June 20, 2024

VIA EDGAR

U.S. Securities and Exchange Commission
Division of Corporation Finance
100 F Street, N.E.
Washington, D.C. 20549

Attn.:	Jimmy McNamara, Esq.
	Office of Life Sciences

Re: OS Therapies Incorporated
Registration Statement on Form S-1 (No. 333-279839)

Ladies and Gentlemen:

On behalf of OS Therapies Incorporated (the “Company”), this letter will serve to withdraw the request for acceleration of the above-referenced Registration Statement filed as correspondence via EDGAR on Tuesday, June 18, 2024.

The Company is no longer requesting that such Registration Statement be declared effective at 4:00 p.m., Eastern Time, on Thursday, June 20, 2024, and we hereby formally withdraw our request for acceleration of the effective date.

Thank you for your assistance.

Very truly yours,

/s/ Spencer G. Feldman

Spencer G. Feldman

cc: Paul A. Romness, MPH

June 20, 2024

U.S. Securities and Exchange Commission
Division of Corporation Finance
100 F Street, N.E.
Washington, D.C. 20549

Attn.:	Jimmy McNamara, Esq.
	Office of Life Sciences

Re: Withdrawal of Acceleration Request
OS Therapies Incorporated
Registration Statement on Form S-1 (No. 333-279839)

Ladies and Gentlemen:

OS Therapies Incorporated hereby withdraws the request for acceleration of the above-referenced Registration Statement filed as correspondence via EDGAR on Tuesday, June 18, 2024.

We are no longer requesting that such Registration Statement be declared effective at 4:00 p.m., Eastern Time, on Thursday, June 20, 2024, and we hereby formally withdraw our request for acceleration of the effective date.

Very truly yours,
OS Therapies Incorporated
By:	/s/ Paul A. Romness
	Paul A. Romness
	President and Chief Executive Officer